Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Matsumoto, H. Inoue, Y. Asai, Y. Matsunaga, Y. Nakanishi (Fukuoka, Japan). B7-H1 is essential for double-stranded RNA-induced augmentation of an asthma phenotype in mice. Eur Respir J 2010; 36: Suppl. 54, 4321

Member's Comments

No comment yet.

Related content which might interest you: Cigarette smoking modulates double-stranded RNA-induced interleukin 6 release from bronchial epithelial cells by decreasing TLR-3 expression Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens Year: 2007 Modified mRNA encoding Foxp3 protects against allergic asthma in mice by rebalancing T helper cell responses through an IL-23 / IL-17A-dependent mechanism Source: Annual Congress 2012 - Treating childhood asthma Year: 2012 T cell specific expression of a short splice variant of the tumor suppressor gene CYLD amplifies the development of allergic airway disease Source: Annual Congress 2011 - T-cell subsets Year: 2011 IFNγ influences bronchial epithelial anti-viral immune responses via inducible epigenetic control of histone methylation of the RIG-I promoter Source: International Congress 2015 – The multiple faces of host defense Year: 2015 HDM-challenged mice exhibit impaired interferon response to TLR3 ligand in a murine model of viral asthma exacerbation Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 CpG oligodeoxynucleotide treatment prevents the development of airway remodelling in a murine model of chronic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002 Double-stranded RNA upregulates TLR3 and induces pro-inflammatory, and innate immune cytokine expression in human bronchial smooth muscle cells Source: Annual Congress 2010 - Airway smooth muscle cells Year: 2010 Allergen immunotherapy downregulate CD86 expression on dendritic cells and upregulate CTLA-4 expression on T cells in a mouse asthma model Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005 Allergen immunotherapy induces a suppressor memory response that is mediated by IL-10 in a mouse model of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 194s Year: 2003 High-level expression of PD-L2 molecules by dendritic cells suppressed the Th2 response in allergic mouse Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007 UPF1 and STAU1 modulate rhinovirus pathophysiology contributing to impaired antiviral immunity in asthma Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 The effect of Immunotherapy on the expression of costimulatory pathway molecules on dendritic cells and T cells in asthmatic mice Source: Eur Respir J 2003; 22: Suppl. 45, 483s Year: 2003 Over-expression of SIGIRR attenuates TLR 4,5,9-mediated immune responses in human airway epithelial cells Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011 Soluble biglycan promotes ovalbumin induced airway inflammation by modulating dendritic cell function in mice Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 siRNA against the p65 subunit of NF-κB modulates the inflammatory response in airway epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 437s Year: 2004 A short splice variant of the tumor suppressor gene CYLD induces allergic airway disease in mice and is also expressed in humans Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Activin-A is a critical inducer of human CD4+ICOS+IL-10-secreting regulatory T cells that suppress allergen-driven T cell responses in vitro and experimental asthma in a humanized mouse model in vivo Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 EP4 agonist increases myeloid derived suppressor cells activity and reduces airway inflammatory events in a murine model of asthma Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015